HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhiqiang Yan Selected Research

Therapeutics

12/2023A potential therapeutic approach for gastric cancer: inhibition of LACTB transcript 1.
1/2023Remodeling liver microenvironment by L-arginine loaded hollow polydopamine nanoparticles for liver cirrhosis treatment.
4/2022Nanoengineered Neutrophils as a Cellular Sonosensitizer for Visual Sonodynamic Therapy of Malignant Tumors.
1/2022Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH- Gastric Cancer.
4/2021A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors.
1/2021LACTB induced apoptosis of oxaliplatin-resistant gastric cancer through regulating autophagy-mediated mitochondrial apoptosis pathway.
1/2020Tetramodal Imaging and Synergistic Cancer Radio-Chemotherapy Enabled by Multiple Component-Encapsulated Zeolitic Imidazolate Frameworks.
1/2019The Application of Nanotechnology in the Codelivery of Active Constituents of Plants and Chemotherapeutics for Overcoming Physiological Barriers during Antitumor Treatment.
1/2019Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo.
1/2018pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhiqiang Yan Research Topics

Disease

42Neoplasms (Cancer)
12/2023 - 01/2011
11Glioblastoma (Glioblastoma Multiforme)
11/2017 - 12/2010
9Stomach Neoplasms (Stomach Cancer)
01/2024 - 09/2018
7Allergic Rhinitis
10/2023 - 06/2005
7Fibrosis (Cirrhosis)
01/2023 - 07/2012
7Glioma (Gliomas)
08/2022 - 12/2013
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2023 - 01/2019
4Inflammation (Inflammations)
04/2022 - 06/2005
4Hypertension (High Blood Pressure)
01/2022 - 12/2004
3Neoplasm Metastasis (Metastasis)
01/2022 - 10/2011
3Body Weight (Weight, Body)
01/2019 - 01/2015
2Infections
01/2024 - 05/2018
2Carcinogenesis
12/2023 - 01/2012
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2022 - 09/2022
2Leukemia
10/2022 - 05/2021
2Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 11/2017
2Vascular Remodeling
01/2021 - 02/2005
2Inborn Genetic Diseases (Disease, Hereditary)
02/2020 - 01/2020
2Breast Neoplasms (Breast Cancer)
04/2017 - 06/2016
2Lung Neoplasms (Lung Cancer)
01/2017 - 01/2011
2Lymphatic Metastasis
06/2015 - 10/2011
2Parkinson Disease (Parkinson's Disease)
11/2014 - 04/2011
1Endometriosis
04/2024
1Infertility (Sterility)
04/2024
1Coccidiosis
01/2024
1Gastritis
12/2023
1Colorectal Neoplasms (Colorectal Cancer)
11/2023
1Hypersensitivity (Allergy)
01/2023
1Portal Hypertension
01/2023
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2022
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
03/2022
1Alcoholic Fatty Liver
01/2022

Drug/Important Bio-Agent (IBA)

13Peptides (Polypeptides)IBA
01/2020 - 01/2012
11Liposomes (Liposome)IBA
04/2022 - 10/2011
10Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 10/2011
9Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 12/2010
8Biomarkers (Surrogate Marker)IBA
12/2023 - 08/2017
6Messenger RNA (mRNA)IBA
01/2024 - 01/2006
6Small Interfering RNA (siRNA)IBA
01/2023 - 01/2018
6Therapeutic UsesIBA
11/2022 - 04/2011
6Chimeric Antigen ReceptorsIBA
11/2022 - 01/2017
6LigandsIBA
10/2017 - 10/2010
5Proteins (Proteins, Gene)FDA Link
01/2024 - 10/2010
5PolymersIBA
04/2021 - 06/2016
4Nanoparticle Drug Delivery SystemIBA
01/2019 - 10/2013
4poly(gamma-glutamylglutamine)paclitaxelIBA
11/2017 - 01/2017
4Neuropilin-1IBA
06/2016 - 10/2013
3CytokinesIBA
01/2024 - 09/2022
3AntigensIBA
11/2022 - 05/2021
3Lipid NanoparticlesIBA
01/2022 - 01/2018
3Prostaglandins DIBA
02/2020 - 07/2019
3Long Noncoding RNAIBA
01/2020 - 09/2018
3Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 01/2012
3MicellesIBA
06/2015 - 12/2010
3PolyethyleneimineIBA
02/2014 - 10/2011
2disitamab vedotinIBA
01/2024 - 01/2022
2Interleukin-10 (Interleukin 10)IBA
01/2024 - 06/2006
2Fluorouracil (Carac)FDA LinkGeneric
11/2023 - 01/2022
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2021
2polydopamineIBA
01/2023 - 08/2019
2HMGB1 Protein (HMG1)IBA
01/2022 - 01/2020
2Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2021 - 01/2021
2Sirtuin 2IBA
01/2021 - 11/2014
2Nucleic AcidsIBA
01/2020 - 01/2018
2CollagenIBA
01/2020 - 01/2019
2AcidsIBA
08/2019 - 01/2017
2RGERPPR peptideIBA
01/2018 - 12/2013
2Gadolinium DTPA (Magnevist)FDA Link
01/2018 - 01/2017
2poly(gamma- glutamylcarbocysteine)paclitaxelIBA
12/2017 - 10/2017
2EnzymesIBA
03/2017 - 06/2005
2monomethoxypolyethylene glycol (MPEG)IBA
06/2015 - 02/2014
2Carbon MonoxideIBA
03/2015 - 06/2005
2IronIBA
01/2015 - 11/2014
2poly(ethylene glycol)-co-poly(ethyleneimine)IBA
02/2014 - 12/2013
2Histamine (Histamine Dihydrochloride)FDA Link
10/2010 - 12/2009
1AntibodiesIBA
04/2024
1Cytokine Receptors (Cytokine Receptor)IBA
01/2024
1artemisinin (artemisinine)IBA
01/2024
1AllergensIBA
10/2023
1Arginine (L-Arginine)FDA Link
01/2023
1AntioxidantsIBA
01/2023
1N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
01/2023
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2023
1PectinsIBA
01/2023
1MesothelinIBA
11/2022
1Interleukin-6 (Interleukin 6)IBA
10/2022
1FluorocarbonsIBA
04/2022
1Oxygen (Dioxygen)IBA
04/2022
1temoporfinIBA
04/2022
1CD7 AntigensIBA
03/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1human ERBB2 proteinIBA
01/2022
1AlbuminsIBA
01/2022

Therapy/Procedure

21Therapeutics
12/2023 - 12/2011
9Drug Therapy (Chemotherapy)
12/2023 - 06/2015
4Immunotherapy
12/2023 - 05/2021
4Precision Medicine
12/2023 - 01/2017
3Radiotherapy
12/2023 - 01/2022
2Intravenous Administration
04/2016 - 01/2015
1Microbubbles
04/2022